Growth Inhibition of Chronic Myelogenous Leukemia Cells by ODN-1, an Aptameric Inhibitor of p210^bcr-ablTyrosine Kinase Activity

Abstract

p210bcr-abl-Related tyrosine kinase activity has been shown to cause chronic myelogenous leukemia (CML), a disease of bone marrow stem cells. Having previously demonstrated that the aptameric oligonucleotide, ODN-1, could inhibit p210bcr-abl kinase activity, the current study sought to determine if ODN-1 could selectively inhibit the growth of CML cells relative to that of normal bone marrow. ODN-1, when introduced by electroporation into peripheral blood mononuclear cells (PBMC) from patients with CML, decreased the number of committed progenitors (CML CFU-GM) by an average of 67%+/-19% (mean+/-SEM, range 28-98%). Treatment of CML PBMC with ODN-1 was also shown to decrease the number of more primitive cobblestone area-forming cells (CAFC) by 35%-87%. In contrast, there was little suppressive effect by the combination of electroporation and ODN-1 on either CFU-GM or CAFC numbers from normal donor bone marrow. These studies suggest that inhibition of p210bcr-abl protein-tyrosine kinase (PTK) activity by ODN-1 is associated with some degree of selective growth inhibition of p210bcr-abl-transformed cells. p210bcr-abl kinase inhibitory agents may be useful for the ex vivo purging of bone marrow or peripheral blood progenitor/stem cells in the setting of autologous transplantation for CML.

Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion

“…Total RNA was isolated with Trizol TM reagent (Life Technologies, Inc.), as previously described (Schwartz et al, 1998). Total RNA, from an equal number of cells (*20 mg), was separated on a 1% agarose formaldehyde gel, transferred onto nylon membrane (Micron Seperations, Inc, Westborough, MA, USA), pre-hybridized in ExpressHyb TM .…”

Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification

“…Reverse transcription was performed with 0.2 mg of either native total RNA or aRNA, using TaqMan reverse transcriptase (Applied Biosystems) with random hexamers, as described previously. 18 For quantitative PCR (qPCR), cDNA, from the equivalent of 40 ng of either total RNA or aRNA were used for each 20 ml reaction, which was performed on an Applied Biosystems 7500 Real Time PCR System workstation, using a TaqMan Universal PCR kit (Applied Biosystems), according to the manufacturer's instructions. Reaction conditions were as follows: 10 min at 501C Â 1, 10 min at 951C Â 1, followed by 40 cycles of 15 s at 951C and 1 min at 601C.…”

Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells

“…Normal diploid peripheral blood mononuclear cells were harvested as previously described from normal volunteers. 15,16 PC3 and PC3-M cells were grown in RPMI 1640 media (Gibco BRL, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS; Bio¯uids, Rockville, MD). DU-145 cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM), supplemented with 5% FBS.…”

“…16 For synthesis of cDNA, 1 mg of total RNA was incubated in a 20 ml reaction mixture containing 16reaction buffer, 5 mM MgCl 2 , 1 mM deoxynucleotide mix, 50 U RNase inhibitor, 20 U AMV reverse transcriptase (Boehringer Mannheim, Indianapolis, IN) and 1.6 mg oligo-dT primer. The reaction mixture was incubated for 10 min at 25 C, followed by 60 min at 42 C and then 5 min at 95 C. PCR detection of PSA utilized nested primers, while single primer pairs were used for the detection of the androgen receptor and beta-actin as described.…”

“…In some experiments, alpha-[ 32 P]-ATP (3000 Ci/mmol, Amersham) was added during the PCR reaction to allow detection by autoradiography, as previously described. 16 In these instances, reaction products were separated on a 10% non-denaturing polyacrylamide gel, and visualized by autoradiography.…”